Bayer vs Medtronic

Iberogast's Big Screen YouTube Strategy Boosts Reach by 17 Points

At the YouTube Festival 2026, Bayer's Consumer Health brand Iberogast presented a case study on shifting TV budget to YouTube to reach younger audiences. Facing an awareness gap among 25-44 year-olds, Bayer used Google's DV360 Reach Planner to model an integrated cross-media plan. The recommendation was to shift 30% of the TV budget to YouTube, targeting Connected TV (Big Screen) with non-skippable ads. The campaign achieved a net reach of 67%, 17 percentage points higher than a pure TV campaign, exactly as predicted. Brand Lift data showed a 41% increase in ad recall and a 7% increase in purchase intent. This pilot has become the new standard for Bayer Consumer Health, which now orchestrates a holistic Big Screen strategy across its brand portfolio, planning linear TV and YouTube together.

• Bayer shifted 30% of Iberogast's TV budget to YouTube as recommended by Google's DV360 Reach Planner.
• The campaign reached 67% net reach in target audience, 17 percentage points higher than a TV-only campaign.
• YouTube reaches 57 million German users monthly, including 20.7 million via Connected TV.

YouTube Festival 2026: Brands See 90% More ROI Than TV

At the YouTube Festival 2026 in Berlin, Google executives and brand marketers highlighted YouTube's growing importance in media planning. Philipp Justus, Google's VP Central Europe, emphasized YouTube's cultural influence, while Marianne Stroehmann presented data showing 90% more ROI compared to TV. Case studies from E.ON and Nestlé demonstrated successful creator collaborations and the effectiveness of YouTube in driving brand consideration and conversions. Bayer's media planning with Display & Video 360 increased reach from 45% to 67%. The event underscored a paradigm shift from traditional TV advertising to creator-driven, culturally embedded content on YouTube.

• Google's YouTube Festival 2026 took place in Berlin on September 17, 2026.
• YouTube reportedly delivers 90% more ROI than TV according to Google.
• E.ON's reality series 'House of Power' increased brand consideration by 2 percentage points.

Prostate Cancer Donut Campaign Launches in Germany

The Urological Health Foundation (USG) has partnered with Bayer Vital and Berlin-based donut chain Brammibal's to launch the 'Ponut', a donut shaped like a buttocks, aimed at raising awareness for prostate cancer screening. The campaign, timed for European Prostate Day on September 15, will distribute the limited-edition donuts free at selected Brammibal's outlets in Berlin and Hamburg. A QR code on the packaging directs users to USG's educational materials. The initiative uses humor to lower men's inhibitions about discussing the topic, as prostate cancer is the most common cancer in men in Germany, with around 70,000 new cases and 15,000 deaths annually. Professor Christian Wülfing, Chief Physician of Urology at Asklepios Klinik Hamburg-Altona and USG Medical Board member, emphasizes the deliberate contrast between the donut and the serious topic to create an engaging conversation starter.

• The Ponut is a donut shaped like buttocks, designed to promote prostate cancer screening.
• Campaign partners include the Urological Health Foundation (USG), Bayer Vital, and Brammibal's donut chain.
• The limited-edition Ponut will be distributed free on September 15 at selected Brammibal's stores in Berlin and Hamburg.

XRlabs Raises €7.48M for AI Surgical Intelligence

London-based XRlabs, a Surgical Intelligence company founded by neurosurgeon Dr. Ali Haddad, has raised €7.48 million ($8.4 million) in Seed funding. The round was led by Playground Global (Palo Alto), with participation from London-based HealthTech investor Eka Ventures. The company develops modular, device-agnostic software that uses computer vision and deep learning to transform live surgical video, navigation telemetry, and pre-operative imaging into a real-time, anatomy-aware view. Its platform has been deployed in over 100 surgical cases across three continents. The funding will support engineering and clinical team expansion, regulatory advancement in the UK, EU, and US, and the extension of clinical evidence. XRlabs also announced Omar Ishrak, former CEO of Medtronic, as Chair of its Board. The company has been awarded compute allocation on the UK AI Research Resource (AIRR).

• XRlabs raised €7.48 million ($8.4 million) in Seed funding led by Playground Global with participation from Eka Ventures.
• Omar Ishrak, former CEO of Medtronic, joined as Chair of XRlabs' Board of Directors.
• The company's platform has been deployed in over 100 surgical cases on three continents.

8-K Financial Filing Analysis for Medtronic (2026-09-01)

On September 1, 2026, Medtronic plc filed a Form 8-K under Item 2.02 (Results of Operations and Financial Condition) announcing its financial results for the first quarter of fiscal year 2027. The details of the quarterly performance were furnished via press release in Exhibit 99.1, signed by Executive Vice President and Chief Financial Officer Thierry Piéton.

• Medtronic plc furnished its Q1 FY2027 financial results via Form 8-K on September 1, 2026.
• The earnings announcement is furnished under Item 2.02 with details provided in Exhibit 99.1.
• The filing was formally authorized and signed by Executive Vice President and CFO Thierry Piéton.

Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.

Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of common stock of MiniMed Group, Inc.